about
Targeting DNA Replication Stress for Cancer TherapyCystatin m: a novel candidate tumor suppressor gene for breast cancer.Novel expression of CST1 as candidate senescence marker.Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells.Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities.Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung CancerLKB1 Tumor Suppressor: Therapeutic Opportunities Knock when LKB1 Is Inactivated.Targeting HER (ERBB) signaling in head and neck cancer: An essential update.O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.Getting familiar with the forthcoming eighth edition of TNM classification of lung cancer: from the T to N and M descriptors.Ethanol alters cellular activation and CD14 partitioning in lipid rafts.Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 statusAddition of bevacizumab for malignant pleural effusion as the manifestation of acquired EGFR-TKI resistance in NSCLC patients.Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC.SBRT to adrenal metastases provides high local control with minimal toxicity.Early detection of lung cancer by using an autoantibody panel in Chinese population.Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.Tuberculosis in umbilical cord blood transplant recipients: clinical characteristics and challenges.EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules.Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma.Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces TogetherO2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological AscorbateNovel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interactionIdentification of recurrent fusion genes across multiple cancer typesSmall Molecule KRAS Agonist for Mutant KRAS Cancer TherapyROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer.Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities?Response to Erlotinib in a Patient with Compound EGFR L747S and Exon 19 DeletionLobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysisMetadherin enhances vulnerability of cancer cells to ferroptosisHER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinibAdvanced stage melanoma therapies: Detailing the present and exploring the futureCentral Nervous System Pseudoprogression With Nivolumab in a Patient With Squamous Cell Lung Cancer Followed by Prolonged ResponseBugs in the system: bringing the human microbiome to bear in cancer immunotherapyContribution of alternative splicing to breast cancer metastasisLow-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung CancerOphiopogon japonicus inhibits radiation-induced pulmonary inflammation in miceCell Block as a Surrogate for Programmed Death-Ligand 1 Staining Testing in Patients of Non-Small Cell Lung CancerHypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop
P50
Q26739923-88CE4CBD-1550-46D3-9A81-B675E20F6543Q33207637-7F1EE77E-F103-4AC0-A125-8FD1A8CD2276Q33920694-5ADB7931-E53E-496F-94E6-9576092A04B3Q34283920-84B2F50E-ACF5-4C23-8198-CEC7DD5C2E85Q36398758-4A4269E8-FA0B-4630-88C4-5C85C0F19638Q37606871-2D9E74D1-92A0-4E5B-B47A-AFA8144F872AQ38354509-193F8DDA-0494-461B-8C73-52684FE35C5DQ38545162-52365506-67BB-49A2-996E-8F2AF8DD625FQ38709364-9E22FA93-F82A-4248-B278-732373E4DD5BQ38800024-A4025E80-9ACC-433A-A6A5-1D1219BB3DD4Q40422089-C3562E1A-0EE8-4B36-9E98-59E7FAFEC83CQ41708717-703C57D4-1E0F-4167-B625-3BE0D62A68A0Q41895086-2A165650-E181-4423-B551-FCEC34CA25BAQ47166342-57B0A6C8-D772-4579-930D-BF6921941DC9Q47275101-6082FE62-9968-4C4F-B5A1-D43CB96E5C62Q47664013-F32B359D-BBB2-40EF-8B9C-8E1FDC60F45AQ47694519-A2AE61E8-8D46-427F-94CF-60970659E743Q48236323-91C2F5D9-ACB3-4A3D-BC97-29E24BE64670Q48708430-94463BF6-D13F-4E9B-A5C5-81B177D22C41Q51663646-DE767630-1C41-4A36-B955-3535D06446E0Q52722210-AD45B541-1AF3-4B29-A898-3EE038696046Q57142019-CE0C851B-88AF-4BEC-B335-1B78424EBE6BQ57598558-5A776A03-6379-4201-B018-E39711A67F24Q58732980-33894FC9-A412-49DF-9DD3-E695425905FDQ61805721-257C657B-1F8A-4616-A618-258B20AFB1CBQ64060362-F8DBFC7B-5A45-470C-B6C5-C07B57451DDBQ64988464-064C4013-2DA3-452A-B19E-E430AEFCCE8EQ88791416-756D7344-AB92-4B63-9ED2-4C2CD0DE2D72Q89216109-C6BE36F2-078B-45A2-9C0C-869734FD64B9Q90041488-B2FE8DC6-8F1F-439B-9EFD-FB462916CD24Q90133807-7A8F79B9-DE2F-4BC6-83CF-861E18EB16C9Q90824069-052B8270-04F4-440B-87DA-C0E7AB3DE934Q91129002-17A82D31-0889-4A82-91CE-672014821AA3Q91236863-3B155429-E732-4BC4-BB7F-58BB362B4380Q91296099-D59E9281-0985-4C36-8F46-B34B3095A9A4Q91319923-EFB2A4F0-2E29-4878-9486-74C87E32C255Q91518286-6573AEBE-481F-41D8-852D-719FF3B5E740Q92593480-DD74507F-67A5-47E0-8F9D-7A99A00BF89CQ92669972-DA31F343-614B-43E1-B2DD-35EE05276465Q92822888-182DE32A-329C-4E4F-BE3D-E3B1313F4610
P50
description
researcher ORCID ID = 0000-0001-7886-6187
@en
name
Jun Zhang
@ast
Jun Zhang
@en
Jun Zhang
@es
Jun Zhang
@nl
type
label
Jun Zhang
@ast
Jun Zhang
@en
Jun Zhang
@es
Jun Zhang
@nl
prefLabel
Jun Zhang
@ast
Jun Zhang
@en
Jun Zhang
@es
Jun Zhang
@nl
P106
P1153
56798681200
P31
P496
0000-0001-7886-6187